Interleukin-7 receptor α (IL-7Rα) deficiency:: cellular and molecular bases.: Analysis of clinical, immunological, and molecular features in 16 novel patients

被引:137
作者
Giliani, S [1 ]
Mori, L
Basile, GD
Le Deist, F
Rodriguez-Perez, C
Forino, C
Mazzolari, E
Dupuis, S
Elhasid, R
Kessel, A
Galambrun, C
Gil, J
Fischer, A
Etzioni, A
Notarangelo, LD
机构
[1] Univ Brescia, Spedali Civili, Dept Pediat, Angelo Nocivelli Inst Mol Med, I-25123 Brescia, Italy
[2] Hop Necker Enfants Malad, INSERM, U429, Paris, France
[3] Hop Debrousse, Unite Immunol & Hematol Pediat, Lyon, France
[4] Technion Israel Inst Technol, B Rappaport Sch Med, Meyer Children Hosp, Haifa, Israel
[5] Hosp Gen Univ Gregorio Maranon, Div Immunol, Madrid, Spain
关键词
D O I
10.1111/j.0105-2896.2005.00234.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Analysis of gene-targeted mice and patients with severe combined immunodeficiency due to mutations of the alpha chain of the interleukin-7 receptor (IL-7Ralpha) has shown important differences between mice and humans in the role played by IL-7 in lymphoid development. More recently, it has been shown that IL-7Ralpha is also shared by the receptor for another cytokine, thymic stromal lymphopoietin (TSLP). In this review, we discuss recent advances in IL-7- and TSLP-mediated signaling. We also report on the clinical and immunological features of 16 novel patients with IL-7Ralpha deficiency and discuss the results of hematopoietic stem cell transplantation.
引用
收藏
页码:110 / 126
页数:17
相关论文
共 113 条
[1]   Essential role of IL-7 receptor α in the formation of Peyer's patch anlage [J].
Adachi, S ;
Yoshida, H ;
Honda, K ;
Maki, K ;
Saijo, K ;
Ikuta, K ;
Saito, T ;
Nishikawa, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (01) :1-6
[2]   Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning [J].
Aiuti, A ;
Slavin, S ;
Aker, M ;
Ficara, F ;
Deola, S ;
Mortellaro, A ;
Morecki, S ;
Andolfi, G ;
Tabucchi, A ;
Carlucci, F ;
Marinello, E ;
Cattaneo, F ;
Vai, S ;
Servida, P ;
Miniero, R ;
Roncarolo, MG ;
Bordignon, C .
SCIENCE, 2002, 296 (5577) :2410-2413
[3]   Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice [J].
Akashi, K ;
Kondo, M ;
vonFreedenJeffry, U ;
Murray, R ;
Weissman, IL .
CELL, 1997, 89 (07) :1033-1041
[4]   A role for thymic stromal lymphopoietin in CD4+ T cell development [J].
Al-Shami, A ;
Spolski, R ;
Kelly, J ;
Fry, T ;
Schwartzberg, PL ;
Pandey, A ;
Mackall, CL ;
Leonard, WJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (02) :159-168
[5]   Suppressors of cytokine signalling (SOCS) in the immune system [J].
Alexander, WS .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :410-416
[6]   Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies:: report of the European experience 1968-99 [J].
Antoine, C ;
Müller, S ;
Cant, A ;
Cavazzana-Calvo, M ;
Veys, P ;
Vossen, J ;
Fasth, A ;
Heilmann, C ;
Wulffraat, N ;
Seger, R ;
Blanche, S ;
Friedrich, W ;
Abinun, M ;
Davies, G ;
Bredius, R ;
Schulz, A ;
Landais, P ;
Fischer, A .
LANCET, 2003, 361 (9357) :553-560
[7]   Cutting edge:: The common γ-chain is an indispensable subunit of the IL-21 receptor complex [J].
Asao, H ;
Okuyama, C ;
Kumaki, S ;
Ishii, N ;
Tsuchiya, S ;
Foster, D ;
Sugamura, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :1-5
[8]   Case report -: B cell function after haploidentical in utero bone marrow transplantation in a patient with severe combined immunodeficiency [J].
Bartolomé, J ;
Porta, F ;
Lafranchi, A ;
Rodríguez-Molina, JJ ;
Cela, E ;
Cantalejo, A ;
Fernández-Cruz, E ;
Gómez-Pineda, A ;
Ugazio, AG ;
Notarangelo, LD ;
Gil, J .
BONE MARROW TRANSPLANTATION, 2002, 29 (07) :625-628
[9]   Primary immunodeficiency diseases due to defects in lymphocytes. [J].
Buckley, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (18) :1313-1324
[10]   Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency [J].
Buckley, RH ;
Schiff, SE ;
Schiff, RI ;
Markert, ML ;
Williams, LW ;
Roberts, JL ;
Myers, LA ;
Ward, FE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (07) :508-516